Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
276studies shown
Showing 133-144 of 276
Drug study icon
CompletedNCT01559272

Safety study of pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in schizophrenia

This study is completed in the United States, in Belgium, in Bulgaria, .... It is testing pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate for schizophrenia.

In Belgium
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Belgium, Bulgaria, ...
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT02417064

Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in France, in Canada, .... It is testing efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

In Belgium
DepressionDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT02422186

Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in France, in the United Kingdom, .... It is testing efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

In Belgium
DepressionDrugOver 65 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT01050582

Safety study of safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Schizophrenia

This study is completed in the United States, in Belgium, in Germany, .... It is testing safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation for Schizophrenia.

In Belgium
Schizophrenia, BipolarityDrugFrom 8 Years to 16 Years
Countries
United States, Belgium, Germany, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT06280235

A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

In Belgium
DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Belgium, Bulgaria, ...
Sponsor
Boehringer Ingelheim
Condition
Depression
Drug study icon
CompletedNCT00232687

A Switch Study of BMS-337039 in Schizophrenic Out-patients

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
France, United Kingdom, Belgium, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.